APYX

$3.74

Post-MarketAs of Mar 17, 8:00 PM UTC

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$3.74
Potential Upside
5%
Whystock Fair Value$3.93
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$153.45M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.66
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-76.15%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
4.16

Recent News

Zacks
Mar 17, 2026

Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Apyx Medical (APYX) have performed compared to their sector so far this year.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MarketBeat
Mar 12, 2026

Apyx Medical Calls AYON a “Game Changer” at Citizens Conference, Targets Profitability in 2025

Apyx Medical (NASDAQ:APYX) executives used a conference discussion at the Citizens Life Sciences Conference to describe what CEO Charlie Goodwin called a fundamentally “different company” following the commercial launch of its AYON platform, and to outline how the new system is reshaping the company

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 10, 2026

Apyx Medical Corp (APYX) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...

Apyx Medical Corp (APYX) reports a significant revenue increase driven by the successful launch of the Aon system, despite a net loss and strategic shifts in focus.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 10, 2026

Apyx Medical Q4 Earnings Call Highlights

Apyx Medical (NASDAQ:APYX) reported record fourth-quarter revenue and highlighted early commercial traction for its AYON body contouring system during its fourth quarter and full year 2025 earnings call. Management said the quarter marked the first full period of AYON sales following the system’s fu

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Associated Press Finance
Mar 10, 2026

Apyx: Q4 Earnings Snapshot

CLEARWATER, Fla. AP) — Apyx Medical Corporation (APYX) on Tuesday reported a loss of $1.3 million in its fourth quarter. The Clearwater, Florida-based company said it had a loss of 3 cents per share.

BEARISH
Negative press. News cycle fixated on risk factors or misses.